Kim, T.-Y.; Park, S.; Kwag, D.; Lee, J.-H.; Lee, J.; Min, G.-J.; Park, S.-S.; Jeon, Y.-W.; Shin, S.-H.; Yahng, S.-A.;
et al. Depth of Response to Intensive Chemotherapy Has Significant Prognostic Value among Acute Myeloid Leukemia (AML) Patients Undergoing Allogeneic Hematopoietic Stem-Cell Transplantation with Intermediate or Adverse Risk at Diagnosis Compared to At-Risk Group According to European Leukemia Net 2017 Risk Stratification. Cancers 2022, 14, 3199.
https://doi.org/10.3390/cancers14133199
AMA Style
Kim T-Y, Park S, Kwag D, Lee J-H, Lee J, Min G-J, Park S-S, Jeon Y-W, Shin S-H, Yahng S-A,
et al. Depth of Response to Intensive Chemotherapy Has Significant Prognostic Value among Acute Myeloid Leukemia (AML) Patients Undergoing Allogeneic Hematopoietic Stem-Cell Transplantation with Intermediate or Adverse Risk at Diagnosis Compared to At-Risk Group According to European Leukemia Net 2017 Risk Stratification. Cancers. 2022; 14(13):3199.
https://doi.org/10.3390/cancers14133199
Chicago/Turabian Style
Kim, Tong-Yoon, Silvia Park, Daehun Kwag, Jong-Hyuk Lee, Joonyeop Lee, Gi-June Min, Sung-Soo Park, Young-Woo Jeon, Seung-Hawn Shin, Seung-Ah Yahng,
and et al. 2022. "Depth of Response to Intensive Chemotherapy Has Significant Prognostic Value among Acute Myeloid Leukemia (AML) Patients Undergoing Allogeneic Hematopoietic Stem-Cell Transplantation with Intermediate or Adverse Risk at Diagnosis Compared to At-Risk Group According to European Leukemia Net 2017 Risk Stratification" Cancers 14, no. 13: 3199.
https://doi.org/10.3390/cancers14133199
APA Style
Kim, T. -Y., Park, S., Kwag, D., Lee, J. -H., Lee, J., Min, G. -J., Park, S. -S., Jeon, Y. -W., Shin, S. -H., Yahng, S. -A., Yoon, J. -H., Lee, S. -E., Cho, B. -S., Eom, K. -S., Kim, Y. -J., Lee, S., Min, C. -K., Cho, S. -G., Lee, J. -W.,
& Kim, H. -J.
(2022). Depth of Response to Intensive Chemotherapy Has Significant Prognostic Value among Acute Myeloid Leukemia (AML) Patients Undergoing Allogeneic Hematopoietic Stem-Cell Transplantation with Intermediate or Adverse Risk at Diagnosis Compared to At-Risk Group According to European Leukemia Net 2017 Risk Stratification. Cancers, 14(13), 3199.
https://doi.org/10.3390/cancers14133199
